Bill Lear, MD, Discusses Development of HEMIGARD ARS
X

SUTUREGARD® Medical, Inc. Blog

 
28Aug

Bill Lear, MD, Discusses Development of HEMIGARD ARS

Bill Lear, MD, Mohs surgeon now but 5-year emergency physician previously, talks with Dr. Mark Plaster of Emergency Physician Monthly about how being an ER doc nurtured his inventive skills which eventually led to his development of the HEMIGARD ARS device. The HEMIGARD ARS device manages lateral wound tension to close excisions, lacerations, and incisions in fragile or high tension or at-risk wounds.

Click the link below under the photo to view the full video

Or Click HERE to view

Related

Press Release - SUTUREGARD® Presenting at the American Society for Mohs Surgery

SUTUREGARD® Medical will be presenting at the American Society for Mohs Surgery (ASMS) Closure Cours...

Read More >

What is Squamous Cell Carcinoma (SCC)?

Squamous cell carcinoma (SCC) is the second most common skin cancer. While basal cell carcinoma (BCC...

Read More >

Why We Use GluSeal® With Our HEMIGARD™- Assisted Skin Closures

Our research has demonstrated that the middle suture in an elliptical wound is under approximately s...

Read More >

Elliptical wound tension and HEMIGARD™

Usually, excisional wounds are created with an ellipse: where the length of the wound is about 2-4 t...

Read More >

MEDICA Press Release - SUTUREGARD® ISR Retention Suture Device

SUTUREGARD® Medical, Inc is pleased to announce that it will be presenting at the MEDICA Internation...

Read More >

Prevent and Manage Wound Dehiscence.

Making wound closure easier for surgeons and better for patients.

Contact Us